跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
福斯利诺 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Lanthanum Carbonate Chewable Tablets
Approved
化学药品
Lanthanum Carbonate Chewable Tablets
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
🇨🇳 National Medical Products Administration
Approval Date
Nov 28, 2025
Approval ID
887SWbEHk37
Company
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Type
化学药品
Approval Details
Approval Id
887SWbEHk37
Approval Number
国药准字HJ20171351
Generic Name
碳酸镧咀嚼片
Generic Name En
Lanthanum Carbonate Chewable Tablets
Trade Name
福斯利诺
Brand Name
福斯利诺
Drug Type
化学药品
Dosage Form
片剂
Strength
500mg(以镧计)
Reg Date
2025-11-28
Expired Date
2030-11-27
Company Name
TAKEDA PHARMACEUTICALS INTERNATIONAL AG IRELAND BRANCH
Production Company Name
HAMOL LIMITED
Company Detail Path
/organization/takeda-pharmaceuticals-international-ag-ireland-branch
Production Company Detail Path
/organization/hamol-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 28, 2025
Approval ID
887SWbEHk37
Type
化学药品
Back to NMPA Approvals